Volterra Technologies’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.53M Buy
31,000
+12,000
+63% +$2.41M 1.48% 11
2026
Q2
$3.61M Sell
19,000
-19,600
-51% -$3.37M 0.52% 49
2026
Q1
$6.52M Buy
38,600
+22,900
+146% +$3.92M 0.79% 26
2025
Q4
$2.65M Buy
+15,700
New +$2.55M 0.27% 97

Other funds holding IBB

Volterra Technologies's IBB Position: Q3 2026 in Review

Volterra Technologies reduced its iShares Biotechnology ETF (IBB) stake by 58% in Q3 2026, selling an estimated $3.4M and leaving 12,359 shares worth $2.6M. The position accounts for 0.59% of the portfolio, ranked #48.

Volterra Technologies first reported a position in IBB in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.57M in Q2 2026. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Volterra Technologies held 12,359 shares of iShares Biotechnology ETF worth $2.6M as of Q3 2026.
  • Volterra Technologies sold 16,938 iShares Biotechnology ETF shares in Q3 2026, an estimated $3.4M.
  • iShares Biotechnology ETF made up 0.59% of Volterra Technologies's portfolio in Q3 2026, its #48 holding.
  • Volterra Technologies first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 4 quarters since.
  • Volterra Technologies's iShares Biotechnology ETF position peaked at $5.57M in Q2 2026.
  • 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Volterra Technologies's 13F filing for Q3 2026, filed 16 Nov 2026.